Jing et al. showed that NAMPTP1 (nicotinamide phosphoribosyltransferase pseudogene 1) can act as an miRNA target, ultimately affecting the prognosis of pancreatic cancer by participating in an NAMPTP1/HCG11-hsa-miR-26b-5p-COL12A competing endogenous RNA network (Jing et al., 2020). This evidence concerns the gene NAMPTP1 and pancreatic neoplasm.